Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)
Clinical trial NCT00093015 · COMPLETED
Trial details
- NCT number
- NCT00093015
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2009-03-01
- Enrollment
- 4038
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.